Natalizumab: A Double-Edged Sword?
Ann Neurol 66:262-263, DeAngelis,L., 2009
Incidental Findings on Brain Magnetic Resonance Imaging: Systematic Review and Meta-analysis
BMJ 339:547-550, 522, Morris,Z.,et al, 2009
Diagnosis and Management of Neuropathic Pain
BMJ 339:391-395, Freynhagen,R. &Bennett,M.I., 2009
Subarachnoid Haemorrhage
BMJ 339:569-570, Hankey,G. &Nelson,M., 2009
Intravascular Lymphoma Masquerading as Multiembolic Stroke Developing After Coronary Artery By-Pass Surgery
The Neurologist 15:98-101, Sumer,M.,et al, 2009
Moyamoya Disease and Moyamoya Syndrome
NEJM 360:1226-1237, Scott,R.M. &Smith,E.R., 2009
Multiple Sclerosis Therapeutics: Unexpected Outcomes Clouding Undisputed Successes
Neurol 72:1008-1015, Wiendl,H. &Hohlfeld,R., 2009
Opportunistic Infections and Other Risks with Newer Multiple Sclerosis Therapies
Ann Neurol 65:367-377, Berger,J.R. &Houff,S., 2009
Diagnostic Value of N-methyl-D-aspartate Receptor Antibodies in Women with New-Onset Epilepsy
Arch Neurol 66:458-464, Niehusmann,P.,et al, 2009
Human Natural Autoantibodies in the Treatment of Neurologic Disease
Neurol 72:1269-1276, Rodriguez,M.,et al, 2009
Recurrent Pericarditis Due to Natalizumab Treatment
Neurol 72:1616-1617, Cohen,M.,et al, 2009
A Systematic Review of Antiepilpetic Drug Initiation and Withdrawal
The Neurologist 15:122-131, Shih,J.J &Ochoa,J.G., 2009
Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis: A Comparative Study
Arch Neurol 66:593-599, Boster,A.,et al, 2009
The Expanding Phenotype of GLUT1-Deficiency Syndrome
Brain & Dev 31:545-552, Brockmann,K., 2009
CNS Complications of Radiotherapy and Chemotherapy
Lancet 374:1639-1651, Soussain,C.,et al, 2009
High-Dose Cytarabine Plus High-Dose Methotrexate Versus High-Dose Methotrexate Alone in Patients with Primary CNS Lymphoma: A Randomised Phase 2 Trial
Lancet 374:1512-1520, 1477, Ferreri,A.,et al, 2009
Scattered Cerebral Microbleeds Due to Cardiac Myxoma
Arch Neurol 66:796-797, Vanacker,P.,et al, 2009
Safety of Biologic Agents After Rituximab Therapy in Patients With Rheumatoid Arthritis
Rheum Int: December 2009, Mishra, R.,et al, 2009
Bilateral Thalamic Lesions
AJR 192:W53-W62, Smith,A.B.,et al, 2009
Diagnosis and Management of Patients at Risk of or with Metastatic Spinal Cord Compression: Summary of NICE Guidance
BMJ 337:1349-1351, White,B.D.,et al, 2008
Patterns of Care in Elderly Glioblastoma Patients
Ann Neurol 64:628-632,597, Iwamoto,F.M.,et al, 2008
Secondary Involvement of the Central Nervous System by Non-Hodgkins Lymphoma
UpToDate (www.uptodate.com) June 9, Norden,A.,et al., 2008
Malignant Gliomas in Adults
NEJM 359:492-507, Wen,P.Y. &Kesari,S., 2008
Anti-Tumor Necrosis Factor Alpha-Associated Multiple Sclerosis
AJNR 26:1548-1550, Titelbaum,D.S.,et al., 2008
Assessment: The Use of Natalizumab (Tysabri) for the Treatment of Multiple Sclerosis (An Evidence-Based Review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 71:766-773, Goodin,D.S.,et al., 2008
Management of Patients With Head Injury
Lancet 372:685-687, Mendelow,A.D.,et al., 2008
Tuberous Sclerosis
Lancet 372:657-658, Curatolo,P.,et al., 2008
Clinicopath Conf., Anti-MNDAR Antibody Mediated Paraneoplastic Limbic Encephalitis Associated With Ovarian Teratoma
NEJM 359:842-853, Case 26-2008, 2008
Monoclonal Antibody Therapies and Neurologic Disorders
Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008
Glatiramer Acetate--Associated, CD30+, Primary, Cutaneous, Anaplastic Large-Cell Lymphoma
Arch Neurol 65:1378-1379, Madray,M.M.,et al, 2008
Meningeal Dissemination in Primary CNS Lymphoma: Prospective Evaluation of 282 Patients
Neurol 71:1102-1108, Fischer,L.,et al, 2008
Familiality in Brain Tumors
Neurol 71:1015-1020, Blumenthal,D.T.&Cannon-Albright,L.A., 2008
Neurologic Manifestations of von Hippel-Lindau Disease
JAMA 300:1334-1342, Butman,J.A.,et al, 2008
Alemtuzumab vs. Interferon Beta-1a in Early Multiple Sclerosis
NEJM 359:1786-1801,1838, The CAMMS223 Trial Investigators, 2008
Primary CNS Lymphoma with Intraocular Involvement: International PCNSL Collaborative Group Report
Neurol 71:1355-1360, Grimm,S.A.,et al, 2008
Cerebellar Leukoencephalopathy: Most Likely Histiocytosis-Related
Neurol 71:1361-1367, van der Knaap,M.S.,et al, 2008
Delayed Leukoencephalopathy with Stroke-Like Presentation in Chemotherapy Recipients
JNNP 79:535-539, Baehring,J.M. &Fulbright,R.K., 2008
Long-Term Outcome in PCNSL Patients Treated with High-Dose Methotrexate and Deferred Radiation
Neurol 70:401-402, Gerstner,E.R.,et al, 2008
Functional Outcome After Language Mapping for Glioma Resection
NEJM 358:18-27, Sanai,N.,et al, 2008
Emergency Administration of Abciximab for Treatment of Patients With Acute Ischemic Stoke: Results of an International Phase III Trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II)
Stroke 39:89-99, Adams,H.P.,Jr.,et al, 2008
Anti-NMDA Receptor Encephalitis in Japan: Long-Term Outcome Without Tumor Removal
Neurol 70:504-511,500, Iizuka,T.,et al, 2008
B-Cell Depletion with Rituximab in Relapsing-Remitting Multiple Sclerosis
NEJM 358:676-688, Hauser,S.L.,et al, 2008
Influence of the Stroke Code Activation Source on the Outcome of Acute Ischemic Stroke Patients
Neurol 70:1238-1243,1232, P�rez de la Ossa,N.,et al, 2008
Opsoclonus-Myoclonus Syndrome Asssociated with Benign Ovarian Teratoma
Neurol 70:1292-1293, Fitzpatrick,A.S.,et al, 2008
Postwithdrawal Rebound Increase in T2 Lesional Activity in Natalizumab-Treated MS Patients
Neurol 70:1150-1151,1073, Vellinga,M.M.,et al, 2008
SOX1 Antibodies Are Markers of Paraneoplastic Lambert-Eaton Myasthenic Syndrome
Neurol 70:924-928, Sabater,L.,et al, 2008
Bacterial and Fungal Meningitis in Patients With Cancer
Neurol 70:943-947, Safdieh,J.E.,et al, 2008
Remission of Refractory Neurosarcoidosis Treated With Brain Radiotherapy: A Case Report and a Literature Review
The Neurologist 14:120-124, Motta,M.,et al, 2008
Spinal Cord Compression in Patients With Advanced Metastatic Cancer
JAMA 299:937-946, Abrahm,J.L.,et al, 2008
Lymphomatoid Granulomatosis Involving Central Nervous System Successfully Treated With Rituximab alone
Arch Neurol 65:662-665, Ishiura,H.,et al, 2008